Delineating the varying activities of IFN-γ during the course of disease provides insight into the complex role of IFN-γ in autoimmunity and illustrates the complexities of treating a disease like PBC with biologics and the concept that one size may not fit all patients. The gene discussed is IFNG; the disease is primary biliary cholangitis.